Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease of tumor growth in mice after intravenous thymosin-treated bone marrow cell injection

D Cupissol, A Rey, A L Goldstein

    Journal of the National Cancer Institute
    |July 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Maternal and neonatal outcome of women before vs. after bariatric surgery: A single tertiary center experience.

    American journal of surgery·2022
    Same author

    eTEP inferior access with tailored retromuscular dissection for small to mid-sized umbilical hernia repair with or without inguinal hernia: early experience.

    Hernia : the journal of hernias and abdominal wall surgery·2022
    Same author

    How-we-do-it: the repair of postoperative ventral hernias after a Mercedes abdominal incision.

    Langenbeck's archives of surgery·2021
    Same author

    Successful management of the open abdomen with hydrocolloid dressing in a resource-constrained setting.

    Hernia : the journal of hernias and abdominal wall surgery·2020
    Same author

    ACTUALITIES IN ENDOCRINOLOGY- PARATHYROID IMAGING.

    Acta endocrinologica (Bucharest, Romania : 2005)·2019
    Same author

    Cryptogenic stroke in hanging. A case report.

    The neuroradiology journal·2013

    Thymosin fraction V and thymosin alpha-1 significantly inhibited tumor growth and extended survival in mice. These thymosin treatments show promise for cancer immunotherapy, unlike theophylline or levamisole.

    Area of Science:

    • Immunology
    • Oncology
    • Pharmacology

    Background:

    • Thymosin peptides modulate immune responses.
    • Investigating immunomodulators for cancer therapy is crucial.
    • Thymosin fraction V and thymosin alpha-1 have shown in vitro immune-enhancing properties.

    Purpose of the Study:

    • To evaluate the in vivo antitumor effects of thymosin fraction V and thymosin alpha-1.
    • To compare the efficacy of thymosin treatments with theophylline and levamisole.
    • To assess the impact on tumor growth and animal survival.

    Main Methods:

    • C57BL/6 mice received intravenous injections of bone marrow cells preincubated with thymosin fraction V or thymosin alpha-1.
    • Tumor growth was monitored for a 3-methylcholanthrene-induced transplantable tumor in a syngeneic model.

    Related Experiment Videos

  • Theophylline and levamisole were used as comparative agents due to their in vitro thymosin-like activity.

    • Main Results:

    • Thymosin fraction V significantly retarded tumor growth (P < 0.001) and prolonged survival (P < 0.001).
    • Thymosin alpha-1 demonstrated similar antitumor effects at one-twentieth the concentration of fraction V.
    • Theophylline and levamisole showed no significant antitumor activity in this model.

    Conclusions:

    • Thymosin fraction V and thymosin alpha-1 exhibit potent in vivo antitumor activity.
    • Thymosin alpha-1 is effective at significantly lower concentrations than thymosin fraction V.
    • These findings support the potential of thymosin peptides as immunotherapeutic agents for cancer treatment.